REQUEST A DEMO
Total
USD $0.00
Search more companies

Adm Korea Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Adm Korea Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The company is a Korea-based company primarily engaged in the provision of clinical trial services. The Company is a contract research organization (CRO) that provides clinical trial related services to pharmaceutical companies and bio ventures. The Company also provides post-marketing research (rPMS) services. The Company was established on October 31, 2003. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on June 3, 2021.

Headquarters
711 Royal Bldg., 5, Dangju-Dong, Jongno-Gu
Seoul; Seoul;

Contact Details: Purchase the Adm Korea Inc. report to view the information.

Website: http://www.admkorea.co.kr

Basic Information
Total Employees:
Purchase the Adm Korea Inc. report to view the information.
Outstanding Shares:
Purchase the Adm Korea Inc. report to view the information.
Registered Capital:
Purchase the Adm Korea Inc. report to view the information.
Financial Auditors:
Purchase the Adm Korea Inc. report to view the information.
Incorporation Date:
October 31, 2003
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
에이디엠코리아(주)
Company Performance
Financial values in the chart are available after Adm Korea Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-7.34%
Total operating revenue
-5.07%
Operating profit (EBIT)
-371.68%
EBITDA
N/A
Net Profit (Loss) for the Period
-4922.46%
Total assets
-4.49%
Total equity
-11.66%
Operating Profit Margin (ROS)
-17.58%
Net Profit Margin
-21.05%
Return on Equity (ROE)
-10.71%
Debt to Equity Ratio
5.81%
Quick Ratio
-1.23%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?